Role of In-House Isolates in Pharmaceutical Quality Control
Are you looking to improve your pharmaceutical quality control? Microbial contamination of pharmaceutical drugs adversely impacts their efficacy and quality presenting a significant patient risk.
It is imperative to monitor the quality of the processing environment with a robust and effective environmental monitoring (EM) programme.
This application note addresses the need to evaluate key sources of contamination to maintain an optimum level of pharmaceutical quality control.
This content was first published by European Pharmaceutical Review (EPR).
Download this application note by Dr. Megha Bajaj, Global Solution Manager at bioMerieux, to discover more about:
- The relevancy of in-house isolates in microbiological QC testing
- The selection and implementation of in-house isolates
- Common microorganisms isolated in pharma labs. Download this document to learn more.
Complete the form below to access the white paper, which will be sent directly to your email after submission. By providing your information, you agree to receive additional emails from bioMérieux about microbiological quality control.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.
